Phase I trial of continuous infusion flavopiridol, a novel cyclin-dependent kinase inhibitor, in patients with refractory neoplasms
(Q52184569)
scientific article published on September 1, 1998
scientific article published on September 1, 1998
Language:
Current Data About
Phase I trial of continuous infusion flavopiridol, a novel cyclin-dependent kinase inhibitor, in patients with refractory neoplasms
other details
description | scientific article published on September 1, 1998 |
External Links
(P356) |
10.1200/JCO.1998.16.9.2986
|
(P698) |
9738567
|